The morphogenetic role of cadherin cell adhesion molecules in human cancer: A thematic review

Cancer Investigation

Volumn 16, Issue 4, 1998, Pages 252-261

  Yap, Alpha S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; UVOMORULIN;

CANCER; CARCINOGENESIS; HUMAN; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031894062     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809039774     Document Type: Review

References (87)

1. Takeichi M: Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811, 1993.
2. Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198:11-26, 1994.
3. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455, 1991.
4. Gumbiner B: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84:345-357, 1996.
5. Takeichi M: Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627, 1995.
6. Larue L, Ohsugi M, Hirchenhain J, et al: E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 91:8263-8267, 1994.
7. Hermiston ML, Gordon JI: In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 129:489-506, 1995.
8. Moll R, Mitze M, Frixen UH, et al: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731-1742, 1993.
9. Berx G, Cleton-Jansen A-M, Nollet F, et al: E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115, 1995.
10. Schipper JH, Frixen UH, Behrens J, et al: E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51:6328-6337, 1991.
11. Dorudi S, Sheffield JP, Poulsom R, et al: E-cadherin expression in colorectal cancer. Am J Pathol 142:981-986, 1993.
12. Bongiorno PF, Al-Kasspooles M, Lee SW, et al: E-cadherin expression in primary and metastatic thoracic neoplasms and in Barret's oesophagus. Br J Cancer 71:166-172, 1995.
13. Kadowaki T, Shiozaki H, Inoue M, et al: E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54:291-296, 1994.
14. Brabant G, Hoang-Vu C, Cetin Y, et al: E-cadherin: A differentiation marker in thyroid malignancies. Cancer Res 53:4987-4993, 1993.
15. Umbas R, Schalken JA, Aalders TW, et al: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109, 1992.
16. Vleminckx K, Vakaet L, Mareel M, et al: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119, 1991.
17. Frixen U, Behrens J, Sachs G, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 117:173-185, 1991.
18. Mbalaviele G, Dunstan CR, Sasaki A, et al.: E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 56:4063-4070, 1996.
19. Brieher WM, Gumbiner BM: Regulation of cadherin function during activin-induced morphogenesis of Xenopus animal caps. J Cell Biol 126:519-527, 1994.
20. Vestweber D, Gossler A, Boller K, et al: Expression and distribution of cell adhesion molecule uvomorulin in mouse preimplantation embryos. Dev Biol 124:451-456, 1987.
21. Brieher WM, Yap AS, Gumbiner BM: Lateral dimerization is required for the homophilic binding activity of C-cadherin. J Cell Biol 135:487-496, 1996.
22. Shapiro L, Fannon AM, Kwong PD, et al: Structural basis of cell-cell adhesion by cadherins. Nature 374:327-337, 1995.
23. Nagar B, Overduin M, Ikura M, et al: Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 380:360-364, 1996.
24. Pokutta S, Herrenknecht K, Kemler R, et al: Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. Eur J Biochem 223:1019-1026, 1994.
25. Nagafuchi A, Takeichi M: Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 7:3679-3684, 1988.
26. Ozawa M, Baribault H, Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8:1711-1717, 1989.
27. McCrea PD, Gumbiner BM: Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). J Biol Chem 266:4514-4520, 1991.
28. Funayama N, Fagotto F, McCrea P, et al: Embryonic axis induction by the armadillo repeat domain of β-catenin: evidence for intracellular signalling. J Cell Biol 128:959-968, 1995.
29. Rimm DL, Koslov ER, Kebriaei P, et al: α1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA 92:8813-8817, 1995.
30. Hirano S, Kimoto N, Shimoyama Y, et al: Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70:293-301, 1992.
31. Watabe M, Nagafuchi A, Tsukita S, et al: Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127:247-256, 1994.
32. Oyama T, Kanal Y, Ochiai A, et al: A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54:6282-6287, 1994.
33. Roh J-Y, Stanley JR: Intracellular domain of desmoglein 3 (pemphigus vulgaris antigen) confers adhesive function on the extracellular domain of E-cadherin without binding catenins. J Cell Biol 128:939-947, 1995.
34. Kintner C: Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell 69:225-236, 1992.
35. Brady-Kalnay SM, Rimm DL, Tonks NK: Receptor protein tyrosine phosphatase PTPμ associates with cadherins and catenins in vivo. J Cell Biol 130:977-986, 1995.
36. cas associates with E-cadherin complexes. Mol Cell Biol 14:8333-8342, 1994.
37. Shibamoto S, Hayakawa M, Takeuchi K, et al: Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol 128:949-957, 1995.
38. Behrens J, Vakaet L, Friis R, et al: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylaion of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757-766, 1993.
39. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J 12:307-314, 1993.
40. Oft M, Peli J, Rudaz C, et al.: TGF-b1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10:2462-2477, 1996.
41. Miettinen PJ, Ebner R, Lopez AR, et al: TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type 1 receptors. J Cell Biol 127:2021-2036.
42. Shibamoto S, Hayakawa M, Takeuchi K, et al: Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Communic 1:295-305, 1994.
43. Hinck L, Nelson WJ, Papkoff J: Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing β-catenin binding to the cell adhesion protein cadherin. J Cell Biol 124:729-741, 1994.
44. Brabant G, Hoang-Vu C, Behrends J, et al: Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro. Endocrinology 136:3113-3119, 1995.
45. Williams CL, Hayes VY, Hummel AM, et al: Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma. J Cell Biol 121:643-654, 1993.
46. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87:159-170, 1996.
47. Oda T, Kanai Y, Oyama T, et al: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad USA 91:1858-1862, 1994.
48. Berx G, Cleton-Jansen A-M, Strumane K, et al.: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925, 1996.
49. Risinger JI, Berchuck A, Kohler MF, et al: Mutations of the E-cadherin gene in human gynecologic cancers. Nature Genetics 7:98-102, 1994.
50. Becker K-F, Atkinson MJ, Reich U: E-cadherin gene mutations provide clues to diffuse type gastric cancer. Cancer Res 54:3845-3852, 1994.
51. Wheelock MJ, Buck CA, Bechtol KB, et al: Soluble 80-kD fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 34:187-202, 1987.
52. 2+-dependent cell-cell adhesion. Cell Adhes Communie 1:239-250, 1993.
53. Candidus S, Bischoff P, Becker K-F, Hofler H: No evidence for mutations in the α- and β-catenin genes in human gastic and breast carcinomas. Cancer Res 56:49-52, 1996.
54. Kingsley DM: The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994.
55. Stevenson WG, Azanavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573, 1993.
56. Nose A, Nagafuchi A, Takeichi M: Expressed recombinant cadherins mediate cell sorting in model systems. Cell 54:993-1001, 1988.
57. Fujimori T, Miyatani S, Takeichi M: Ectopic expression of N-cadherin perturbs histogenesis in Xenopus embryos. Development 110:97-104, 1990.
58. Steinberg MS, Takeichi M: Experimental specification of cell sorting, tissue spreading, and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci USA 91:206-209, 1994.
59. Byers SW, Sommers CL, Hoxter B, et al: Role of E-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: Measurement of cell-cell adhesion strength. J Cell Sci 108:2053-2064, 1995.
60. Huttenlocher A, Sandborg RR, Horwitz AF: Adhesion in cell migration. Curr Opin Cell Biol 7:697-706, 1995.
61. Giancotti FG, Mainiero F: Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta 1198:47-64, 1994.
62. Finnemann S, Kuhl M, Otto G, et al: Cadherin transfection of Xenopus XTC cells downregulates expression of substrate adhesion molecules. Mol Cell Biol 15:5082-5091, 1995.
63. Hodivala KJ, Watt FM: Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte differentiation. J Cell Biol 124:589-600, 1995.
64. Faggotto F, Gumbiner B: Cell contact-dependent signaling. Dev Biol 180:445-454, 1996.
65. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Biol 11:549-599, 1995.
66. Caveda L, Martin-Padura I, Navarro P, et al: Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest 98:886-893, 1996.
67. Gumbiner B, Stevenson B, Grimaldi A: The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107:1575-1587, 1988.
68. Gumbiner B: Signal transduction by β-catenin. Curr Opin Cell Biol 7:634-640, 1995.
69. Behrens J, von Kries JP, Kuhl M, et al: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382:638-642, 1996.
70. McCrea PD, Brieher WM, Gumbiner BM: Induction of a secondary body axis in Xenopus by antibodies to β-catenin. J Cell Biol 123:477-484, 1993.
71. Heasman J, Crawford A, Goldstone K, et al: Overexpression of cadherins and underexpression of β-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell 79:791-803, 1994.
72. Fagotto F, Funayama N, Gluck U, et al: Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus. J Cell Biol 132:1105-1114, 1996.
73. Nusse R, Varmus HE: Wnt genes. Cell 69:1073-1087, 1992.
74. Hermiston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203-1207, 1995.
75. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437-1443, 1985.
76. Navarro P, Lozano E, Cano A: Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. J Cell Sci 105:923-934.
77. Reichmann E, Schwarz H, Deiner EM, et al: Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103-1116, 1992.
78. Fialka I, Schwarz H, Reichmann E, et al: The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 132:1115-1132, 1996.
79. Yoshiura K, Kanai Y, Ochiai A, et al: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416-7419, 1995.
80. Vleminckx KL, Deman JJ, Bruyneel EA, et al: Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res 54:873-877, 1994.
81. 1 colon carcinoma. Science 275:1784-1787, 1997.
82. van de Wetering M, Cavallo R, Dooijes D, et al: Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789-799, 1997.
83. Riese J, Yu X, Munnerlyn A, et al: LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 88:777-787, 1997.
84. Rubinfeld B, Souza B, Albert I: Association of the APC gene product with β-catenin. Science 262:1731-1734, 1993.
85. Su L-K, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737, 1993.
86. Morin PJ, Sparks AB, Korinek V, et al: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790, 1997.
87. Rubinfeld B, Robbins P, El-Gamil M, et al: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792, 1997.